Association of COVID-19 with MucormycosisAn Appalling and Enervating Disease in North-western India
Correspondence Address :
Dr. Megha Shukla Pandey,
Associate Professor, Department of Pathology, American International Institute of
Medical Sciences, Udaipur-313001, Rajasthan, India.
E-mail: drmeghashukla@yahoo.com
Introduction: The pandemic Coronavirus Disease-2019 (COVID-19) continues to be a significant problem worldwide. The disease pattern ranges from mild to life threatening pneumonia. Association of COVID-19 with mucormycosis is rare but an increase in this association has been observed recently, particularly in a background of immunocompromised state with rhino-orbital-cerebral region being the most common site of involvement.
Aim: To study the site and presentation of mucormycosis in COVID-19 patients with histopathological association.
Materials and Methods: A descriptive study was conducted at American International Institute of Medical Sciences, Udaipur, Rajasthan, India, in which first 20 patients of COVID-19 with mucormycosis of rhino-orbital region were included in the study. The study was conducted for a period of two months (April-May 2021). Detailed clinical history and associated co-morbidities were noted for each patient. Histopathological examination of all the specimens resected for fungal infection was done along with special stain. Statistical analysis was done using Chisquare test.
Results: COVID-19 association with mucormycosis was observed in all 20 cases. Maximum number of cases (11) were present in the age group of 20-40 years. Diabetes Mellitus (DM) had a strong association with mucormycosis. Maxillary sinus was most commonly associated site. Preoperative Potassium Hydroxide (KOH) was positive in all 20 cases, detailed histopathology study along with Periodic Acid Schiff (PAS) stain was performed in all cases. Additional microscopic findings like angioinvasion (03), granuloma (01) and giant cell reaction (13) were also recorded.
Conclusion:COVID-19 has emerged as a global threat to mankind. In the present scenario the entire medical fraternity should have a prompt and team approach towards the management of this pandemic, in terms of, early detection of the infection, meticulous use of corticosteroids and screening of co-morbidities to safeguard patients from such life threatening fungal infections.
: Co-morbidities, Coronavirus disease 2019, Diabetes mellitus, Opportunistic infections, Pneumonia
10.7860/JCDR/2021/50748.15678
Date of Submission: Jun 08, 2021
Date of Peer Review: Aug 31, 2021
Date of Acceptance: Oct 23, 2021
Date of Publishing: Nov 01, 2021
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jun 10, 2021
• Manual Googling: Oct 22, 2021
• iThenticate Software: Oct 28, 2021 (4%)
ETYMOLOGY: Author Origin
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase
- EBSCOhost
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)
- www.omnimedicalsearch.com